Lu-177: a game-changer

Vyas, Madhusudan; Fagan, Jessica

Thumbnail
Share
View fulltext online
Date
2018-09
Citation:
Vyas, M. & Fagan, J. (2018, Sepetmber). Lu-177: A Game-changer. Paper presented at the ANZSNM- Annual Branch Meeting-2018, Invercargill,New Zealand.
Permanent link to Research Bank record:
https://hdl.handle.net/10652/4460
Abstract
Theranostics Lu-177 : timeline Why Lu-177 is better Various Lu-177 labelled Radiopharmaceuticals in use Teaser for the future in New Zealand
Keywords:
neuroendocrine tumours (NETs), Lu-177, Lutetium-177, theranostics, prostate cancer, radionuclide therapy, New Zealand
ANZSRC Field of Research:
1112 Oncology and Carcinogenesis, 110313 Nuclear Medicine
Copyright Holder:
Authors

Copyright Notice:
All rights reserved
Rights:
This digital work is protected by copyright. It may be consulted by you, provided you comply with the provisions of the Act and the following conditions of use. These documents or images may be used for research or private study purposes. Whether they can be used for any other purpose depends upon the Copyright Notice above. You will recognise the author's and publishers rights and give due acknowledgement where appropriate.
Metadata
Show detailed record
This item appears in